Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aeonmed›
News
AddedJul 2, 2026
UpdatedJul 2, 2026
Aeonmed

Aeonmed

Series A

Aeonmed is a leading Chinese manufacturer of anesthesia and respiratory medical equipment for OR and ICU.

HQ
Beijing, Beijing, CN
Founded
2001
Loading
Overview
Compare
Fundraising
Employees
News
Website

Latest News About Aeonmed

ACXEL (Aosu Tech) ranked #1 in growth category of 2025 China Globalization New Forces 100

Cyzone / 创业邦 via Qiming

ACXEL (Aosu Tech) ranked #1 in growth category of 2025 China Globalization New Forces 100

ACXEL (acx INSTRUMENTS) was selected in the 2025 China Enterprise Globalization New Forces 100 list by Cyzone/36Kr in the growth enterprise...

Jul 15, 2025

Orrick represents AEONMED in successful action against ministerial prohibition to acquire Heyer

Orrick

Orrick represents AEONMED in successful action against ministerial prohibition to acquire Heyer

Aeonmed successfully challenged the German government's prohibition on its acquisition of Heyer Medical AG in court.

Nov 16, 2023

Aeonmed and Heyer Will Attend virtual.MEDICA as Leading Ventilator Suppliers In 2020

Business Wire

Aeonmed and Heyer Will Attend virtual.MEDICA as Leading Ventilator Suppliers In 2020

Having supplied more than 50,000 units of ventilators around the world during the COVID-19 pandemic.

Nov 12, 2020

Aeonmed on Bloomberg: China’s factories work 24/7 to build ventilators for Milan, New York

Qiming Venture Partners / Bloomberg

Aeonmed on Bloomberg: China’s factories work 24/7 to build ventilators for Milan, New York

Aeonmed ramps up ventilator production during COVID-19 pandemic to supply global demand.

Mar 24, 2020

Aeonmed acquires HEYER Medical AG

Aeonmed

Aeonmed acquires HEYER Medical AG

In 2019, Aeonmed acquired German company HEYER Medical AG (founded 1883), a leader in OR and ICU equipment.

Oct 1, 2019